Exhibition Review 丨 2024 BIOCHINA South China, how Tongteng Biological strength ‘out of the circle’?

Release date:2024-10-21



In the brilliant chapter of October, 2024 BIOCHINA South China concluded in Guangzhou Nanfeng International Convention and Exhibition Centre. In this feast, which gathered elites and cutting-edge achievements in the field of biotechnology, Tongteng Biologicals, with its excellent innovative strength and forward-looking technical vision, made a wonderful appearance and won wide attention and praise.


At Tongteng Biotech with its four star products made a stunning appearance at the exhibition: CEL-G®Culture Ad60 series fixed-bed bioreactor, Refeyn single-molecule mass analyser system, heliXcyto native molecule-interacting cell analyser system, and I.DOT non-contact liquid handling system.



The stunning debut of these four products instantly attracted the attention of professionals across the venue, becoming the core topic of heated discussion and in-depth exploration on the show floor. Visitors were in constant flow, showing great interest in exploring the technical details behind the products, stopping to ask questions and exchange ideas. Tongteng Bio's booth was crowded and bustling, becoming a bright landscape at the exhibition.



It is especially worth mentioning that during the exhibition, Tongteng Bio was honoured to receive a live interview from the organizer. Our on-site application scientists, through the online platform at the booth, carried out in-depth technical exchanges and product sharing with online and offline visitors. Their professional answers and vivid demonstrations not only gave the audience a more intuitive and in-depth understanding of Tongteng Bio's products, but also further promoted the exchange of technical wisdom and the sprouting of co-operation intention in the industry.



With the successful conclusion of ‘2024 BIOCHINA South China’, Tongteng Bio will continue to uphold the spirit of craftsmanship, constantly upgrade products, improve service technology, and is committed to injecting innovative power and unlimited possibilities into the field of biomedicine.